Tang Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.9M | Hold |
10,029,500
| – | – | 4.29% | 3 |
|
|
2025
Q1 | $80.6M | Buy |
10,029,500
+1,600,000
| +19% | +$12.9M | 4.46% | 3 |
|
|
2024
Q4 | $75.7M | Buy |
8,429,500
+1,200,000
| +17% | +$10.8M | 5.01% | 2 |
|
|
2024
Q3 | $53M | Buy |
7,229,500
+4,450,000
| +160% | +$32.6M | 3.79% | 3 |
|
|
2024
Q2 | $15.9M | Buy |
2,779,500
+729,500
| +36% | +$4.17M | 1.62% | 19 |
|
|
2024
Q1 | $10.3M | Buy |
2,050,000
+1,500,000
| +273% | +$7.52M | 1.07% | 31 |
|
|
2023
Q4 | $4.94M | Sell |
550,000
-200,000
| -27% | -$1.8M | 0.46% | 56 |
|
|
2023
Q3 | $5.83M | Buy |
750,000
+600,000
| +400% | +$4.66M | 0.82% | 38 |
|
|
2023
Q2 | $1.45M | Buy |
+150,000
| New | +$1.45M | 0.21% | 76 |
|
|
2023
Q1 | – | Sell |
-200,000
| Closed | -$864K | – | 106 |
|
|
2022
Q4 | $864K | Hold |
200,000
| – | – | 0.13% | 71 |
|
|
2022
Q3 | $1.5M | Buy |
+200,000
| New | +$1.5M | 0.18% | 75 |
|